Italian researchers develop advanced cancer testing system
NCT ID NCT07403630
Summary
This study is testing a new diagnostic platform called IT-TCP that analyzes tumor samples from patients with high-risk cancers. Researchers will collect samples from 300 patients with various cancers including leukemia, pancreatic cancer, and melanoma to see if this detailed analysis can help guide treatment decisions. The goal is to determine if this advanced testing approach changes treatment recommendations compared to standard methods.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AO Riuniti Villa Sofia-Cervello di Palermo
RECRUITINGPalermo, Palermo, 90146, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Perugia
RECRUITINGPerugia, Perugia, 06123, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.